Hence, these findings reflected that a decline in Hb was expected among BC patients undergoing chemotherapy irrespective of their stages of cancer, age at diagnosis, pre-treatment Hb or types of chemotherapy or concomitant radiotherapy and hormonal treatment. The gene discussed is GSTM1; the disease is breast cancer.